「oswindows 7」の検索結果
284件：41～45件目を表示
もしかして
-
9 年） 2)：Z. Pan et al. Invest Ophthalmol Vis Sci. 2011; 52(1): 485-93., P. Rozas et al. Pain 2016; 157(6):1346-62. 等 3)：Y. Sakane et al. JAMA Ophthalmol. 2013;131(10):1331-1338. 「アバレプト®懸濁性点眼液 0.3%」の製品概...
https://www.senju.co.jp/system/files/content_news/2026-04/JPN_20260406.pdf -
019) 2)：Z. Pan et al. Invest Ophthalmol Vis Sci. 2011; 52(1): 485-93., P. Rozas et al. Pain 2016; 157(6):1346-62. 3)：Y. Sakane et al. JAMA Ophthalmol. 2013;131(10):1331‐1338. Product Overview Product ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical
side effects and accidents.) 1. The following persons should not use this medicine: Children under 7 years Women who are or may be pregnant Women who are breastfeeding 2. Do not operate vehicles or m...
http://www.senju.co.jp/english/products/ap.html -
Mytear ALPITATTO NEXα | OTC Products, etc. | Products | SENJU Pharmaceutical
side effects and accidents.) 1. The following persons should not use this medicine: Children under 7 years Women who are or may be pregnant Women who are breastfeeding 2. Do not operate vehicles or m...
http://www.senju.co.jp/english/products/nex.html